PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Shanghai Institute of Hematology, State Key Laboratory of Medical Genomics, National Research Center for Translational Medicine at Shanghai, Ruijin Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, 200025, China.\', \'Shanghai Public Health Clinical Center, Shanghai, 201508, China.\', \'National Institutes for Food and Drug Control (NIFDC), Beijing, 102629, China.\', \'Shanghai Public Health Clinical Center, Shanghai, 201508, China. luhongzhou@shphc.org.cn.\', \'Shanghai Institute of Hematology, State Key Laboratory of Medical Genomics, National Research Center for Translational Medicine at Shanghai, Ruijin Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, 200025, China. sjchen@stn.sh.cn.\']
?:citedBy
  • -1
?:creator
?:doi
  • 10.1007/s11684-020-0822-5
?:doi
?:hasPublicationType
?:journal
  • Frontiers of medicine
is ?:pmid of
?:pmid
?:pmid
  • 33017040
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 0.913
?:rankingScore_hIndex
  • 25
?:title
  • Durability of neutralizing antibodies and T-cell response post SARS-CoV-2 infection.
?:type
?:year
  • 2020

Metadata

Anon_0  
expand all